The Best of Ophthalmology.....EyeWorld News Magazine

May 2008

EW WEEK Vol. 13 No. 13

· Pfizer drops trials of NicOx glaucoma drug
· RegenRx awarded patent in Hong Kong
· FDA grants request to expand Neovista’s CABERNET trial
· Bepreve demonstrates efficacy in Phase III trial

View this Issue

Would you like to receive EyeWorld Week?

Monthly Poll

Resources

Ophthalmologists

Practice Managers

Consumers

NYU-ASCRS Podcasting

EyeSpaceMD

Past Surveys

1.	Do you believe glistenings can become severe enough to affect a patient’s visual acuity? View Final Results
2.	Is ectasia preventable? View Final Results
3.	Will SBK become the preferred refractive procedure? View Final Results
4.	Are you concerned about the risk of contamination in preservative-free, multi-use bottles of ophthalmic solutions? View Final Results
5.	Do you perform endothelial keratoplasty? View Final Results
6.	Is trabeculectomy the best surgical option for reducing intraocular pressure in glaucoma patients? View Final Results
7.	During cataract surgery, do you ever use clear corneal incisions? View Final Results
8.	Are prostaglandins the first drug you use to treat patients with high IOP? View Final Results
9.	Should top-performing employees receive incentives such as additional vacation time? View Final Results
10.	If a cataract specialist has received training, should he/she perform a pars plana vasectomy? View Final Results
11.	Is the management of corneal haze after PRK still a major challenge for ophthalmologists? View Final Results
12.	Do you believe accommodative IOLs are the best future hope for presbyopes (as opposed to multifocal IOLs)? View Final Results
13.	Do you think wavefront-guided surface ablation yields better final UCVA than wavefront-guided LASIK? View Final Results
14.	Do you believe LASEK offers better final UCVA than PRK? View Final Results
15.	Do you believe surface ablation is making a resurgence? View Final Results
16.	Two new NSAIDs, Nevanac (Alcon, Fort Worth, Texas) and Xibrom (ISTA Pharmaceuticals, Irvine, Calif.), have received approval from the Food and Drug Administration this year. Do you think they are substantial improvements over other NSAIDs? View Final Results
17.	Do you believe more studies are needed to demonstrate the safety of trypan blue? View Final Results
18.	Do you believe the sharp-edge design has been the most important IOL development in reducing posterior capsule opacification? View Final Results
19.	Have you or others in your practice begun implanting phakic or presbyopic intraocular lenses? View Final Results
20.	Do you believe the clear corneal incision generally has lead to a higher incidence of endophthalmitis than the scleral tunnel incision? View Final Results
21.	Do you currently use or plan to use surgical glue for any ophthalmic procedures? View Final Results
22.	The Centurion SES Epikeratome-which employs a dull plastic edge to remove epithelium during a refractive surgical procedure known as Epi-LASIK-has shown promising results internationally. Do you think its results obtained by U.S. investigators will show Epi-LASIK to be a better refractive modality than LASIK? View Final Results
23.	Will you use trypan blue more during some cataract surgeries now that the Food and Drug Administration has approved one brand of the dye? View Final Results
24.	Do your patients regularly have questions about AMD treatment? View Final Results
25.	Would you use Restasis therapy as the first line of defense for severe dry eye? View Final Results

Contribute | Editorial Board | Advertiser Index | Publishing Statement | Advertise with Us

Visit EyeWorld.mobi for a PDA optimized experience